| 名稱(chēng) | ICOS Effector Reporter Cell |
| 型號(hào) | CBP74063 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | ICOS Effector Reporter Cell，凍存條件：90% FBS+10% DMSO； |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 【靶點(diǎn)模型+診斷質(zhì)控】c-Kit常見(jiàn)突變的藥物開(kāi)發(fā)和診斷
- 腫瘤細(xì)胞培養(yǎng)實(shí)驗(yàn)的主要用途
- 【新品上線(xiàn)】AXL篩選模型
- Nectin-4, ADC賽道新星靶點(diǎn)
- Cell Metab：雙信號(hào)通路失調(diào)協(xié)同促進(jìn)肺癌形成
- 細(xì)胞株開(kāi)發(fā)的主要過(guò)程要知道
- 2017腫瘤研究的方向是什么？
- 4-1BB（CD137）靶點(diǎn)藥物篩選模型
- 你知道ATCC細(xì)胞如何解凍嗎？
- EGFR 20外顯子突變類(lèi)型標(biāo)準(zhǔn)品
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74063ICOS Effector Reporter Cell
- 詳細(xì)內(nèi)容
ICOS Effector Reporter Cell
| CBP74063 | |
| I. Background | |
| ICOS is a costimulatory molecule of the CD28 cell surface receptor superfamily that is expressed on activated T-cells. ICOS is involved in T-cell responses upon binding with its ligand, ICOSL (also known as B7-H2, CD275), which is normally expressed on B-cells, dendritic cells and monocytes. | |
| II. Description | |
ICOS expression confers an activated phenotype and a strong suppressive capacity to intra-tumoral regulatory T-cells. The ICOS/ICOSL pathway is a key target for cancer immunotherapy. | |
| III. Introduction | |
| Expressed gene: | ICOS |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | T-cell costimulator, CD278 |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+800ug/ml hygromycin+10ug/ml blasticidin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| IV. Representative Data | |
Figure 1. Dose response of Anti-lCOS Ab in ICOS Effector Reporter Cells(C5). | |
會(huì)員_a.png)